Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives MI Ugwoke, RU Agu, N Verbeke, R Kinget Advanced drug delivery reviews 57 (11), 1640-1665, 2005 | 701 | 2005 |
The lung as a route for systemic delivery of therapeutic proteins and peptides R Uchenna Agu, M Ikechukwu Ugwoke, M Armand, R Kinget, N Verbeke Respiratory research 2, 1-12, 2001 | 545 | 2001 |
Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers KS Paudel, DC Hammell, RU Agu, S Valiveti, AL Stinchcomb Drug development and industrial pharmacy 36 (9), 1088-1097, 2010 | 132 | 2010 |
Studies on the antidiarrhoeal properties of Pentaclethra macrophylla leaf extracts PA Akah, CN Aguwa, RU Agu Phytotherapy Research: An International Journal Devoted to Pharmacological …, 1999 | 91 | 1999 |
Scintigraphic evaluation in rabbits of nasal drug delivery systems based on carbopol 971p® and carboxymethylcellulose MI Ugwoke, RU Agu, H Vanbilloen, J Baetens, P Augustijns, N Verbeke, ... Journal of controlled release 68 (2), 207-214, 2000 | 84 | 2000 |
Safety assessment of selected cyclodextrins—effect on ciliary activity using a human cell suspension culture model exhibiting in vitro ciliogenesis RU Agu, M Jorissen, T Willems, G Van den Mooter, R Kinget, N Verbeke, ... International journal of pharmaceutics 193 (2), 219-226, 2000 | 61 | 2000 |
Drug-eluting nasal implants: formulation, characterization, clinical applications and challenges A Parikh, U Anand, MC Ugwu, T Feridooni, E Massoud, RU Agu Pharmaceutics 6 (2), 249-267, 2014 | 59 | 2014 |
Nasal toxicological investigations of Carbopol 971P formulation of apomorphine: effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit … MI Ugwoke, RU Agu, M Jorissen, P Augustijns, R Sciot, N Verbeke, ... European journal of pharmaceutical sciences 9 (4), 387-396, 2000 | 59 | 2000 |
In‐vitro nasal drug delivery studies: comparison of derivatised, fibrillar and polymerised collagen matrix‐based human nasal primary culture systems for nasal drug delivery studies RU Agu, M Jorissen, T Willems, P Augustijns, R Kinget, N Verbeke Journal of Pharmacy and Pharmacology 53 (11), 1447-1456, 2001 | 57 | 2001 |
In vitro and in vivo testing methods for respiratory drug delivery RU Agu, MI Ugwoke Expert opinion on drug delivery 8 (1), 57-69, 2011 | 52 | 2011 |
Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium RU Agu, HV Dang, M Jorissen, T Willems, R Kinget, N Verbeke International journal of pharmaceutics 237 (1-2), 179-191, 2002 | 51 | 2002 |
Proton-coupled oligopeptide transporter (POT) family expression in human nasal epithelium and their drug transport potential R Agu, E Cowley, D Shao, C MacDonald, D Kirkpatrick, K Renton, ... Molecular pharmaceutics 8 (3), 664-672, 2011 | 44 | 2011 |
Toxicological investigations of the effects carboxymethylcellulose on ciliary beat frequency of human nasal epithelial cells in primary suspension culture and in vivo on rabbit … MI Ugwoke, RU Agu, M Jorissen, P Augustijns, R Sciot, N Verbeke, ... International journal of pharmaceutics 205 (1-2), 43-51, 2000 | 44 | 2000 |
Effects of pharmaceutical compounds on ciliary beating in human nasal epithelial cells: a comparative study of cell culture models R Uchenna Agu, M Jorissen, T Willems, G Van den Mooter, R Kinget, ... Pharmaceutical research 16, 1380-1385, 1999 | 44 | 1999 |
Models for the study of nasal and sinus physiology in health and disease: A review of the literature AA Al‐Sayed, RU Agu, E Massoud Laryngoscope investigative otolaryngology 2 (6), 398-409, 2017 | 37 | 2017 |
Improving the efficiency of respiratory drug delivery: a review of current treatment trends and future strategies for asthma and chronic obstructive pulmonary disease A Shakshuki, RU Agu Pulmonary Therapy 3 (2), 267-281, 2017 | 36 | 2017 |
Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium RU Agu, HV Dang, M Jorissen, R Kinget, N Verbeke Peptides 25 (4), 563-569, 2004 | 34 | 2004 |
Novel mucoadhesive polymers for nasal drug delivery U Anand, T Feridooni, RU Agu Recent advances in novel drug carrier systems, 315-330, 2012 | 33 | 2012 |
Characterization of Calu-3 cell monolayers as a model of bronchial epithelial transport: organic cation interaction studies C MacDonald, D Shao, A Oli, RU Agu Journal of drug targeting 21 (1), 97-106, 2013 | 30 | 2013 |
In situ and ex vivo nasal models for preclinical drug development studies RU Agu, MI Ugwoke Drug absorption studies: In situ, in vitro and in silico models, 112-134, 2008 | 30 | 2008 |